Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > The Coombs research

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Jul 26, 2021 11:47am

193 Views

Post# 33604461

RE:The Coombs research

tamarindo, Dr Coombs has nothing to do with this. He is in charge of the bio lab at U of Mantoba. This announcement was a deal with the Canadian governments National Microbio Lab for virus research headed by Dr Kobasa. It followed up on Coombs work with 1433 on viruses at his lab.
While they are geographically very close to each other and closely follow each others work, they are separate entities.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec